Elevance Health (ELV) Notes Payables (2009 - 2026)

Elevance Health (ELV) has 18 years of Notes Payables data on file, last reported at $724.0 million in Q1 2026.

• On a quarterly basis, Notes Payables rose 189.6% year-over-year to $724.0 million in Q1 2026; TTM through Mar 2026 was $724.0 million, a 189.6% increase from a year earlier, with the FY2025 full-year figure at $150.0 million, down 58.9% from the prior year.
• Notes Payables for Q1 2026 stood at $724.0 million, up from $150.0 million in the prior quarter.
• Over the last five years, Notes Payables for ELV reached as high as $1.6 billion in Q1 2024 and fell as low as $150.0 million in Q4 2025.
• Historically, Notes Payables has averaged $370.2 million across 5 years, with a median of $265.0 million in 2022.
• Across the five-year window, Notes Payables surged 494.34% in 2024 and slumped 84.13% in 2025, its largest moves.
• Year by year, Notes Payables stood at $265.0 million in 2022, then fell by 15.09% to $225.0 million in 2023, then jumped by 62.22% to $365.0 million in 2024, then tumbled by 58.9% to $150.0 million in 2025, then surged by 382.67% to $724.0 million in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $724.0 million in Q1 2026, $150.0 million in Q4 2025, and $180.0 million in Q3 2025.